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germline mutation in telomerase. A 60-year-old woman
presented with defective wound healing after multiple
surgical explorations of the chest wall to exclude breast
cancer recurrence. At age 42, she received a diagnosis of
stage I estrogen receptorepositive left breast infiltrating
ductal carcinoma on routine mammography. Lumpec-
tomy with axillary node dissection revealed T1N0 dis-
ease. Her adjuvant radiation therapy consisted of 50.4 Gy
in 28 fractions followed by a 10-Gy boost in 5 fractions
to the tumor bed. She did well for 12 years, when a left
rib fracture was incidentally noted on imaging. This
prompted multiple needle biopsies which showed atypia
but no malignancy. Open surgical biopsy revealed the
anterior ribs within the radiation field were replaced with
soft tissue, but no malignancy was found. The post-
operative course was complicated by multiple wound
infections requiring surgical debridement and failed
healing of skin grafts left her with an open chest wall
wound (Fig. 1A).
She was evaluated at our center for a second opinion.
Computed tomography (CT) imaging showed fractured left
ribs and chest wall abnormalities consistent with radiation
necrosis. In addition, in the contralateral lung, there was
basilar honeycombing characteristic of idiopathic pulmo-
nary fibrosis (IPF) (Fig. 1A and B). Family history revealedReprint requests to: Mary Armanios, MD, 1650 Orleans St, Cancer
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http://dx.doi.org/10.1016/j.ijrobp.2015.08.0482 siblings who died from IPF and myelodysplastic syn-
drome, a complex pathognomonic for the diagnosis of a
short telomere syndrome (2). Genetic evaluation revealed a
deleterious mutation in the telomerase RNA gene, TR, that
was also found in her siblings (n.80, T>A). The mutation
predicted disruption of the essential pseudoknot domain of
TR and was associated with short telomere length, below
the age-adjusted 10th percentile (Fig. 1C). Additional chest
wall reconstruction was deferred given the known risk of
respiratory failure after anesthesia and elective surgery in
IPF patients (3). During the subsequent year, her wound
improved with conservative care, but she developed wors-
ening respiratory symptoms, and subsequently died cancer-
free from end-stage lung disease.
In order to test whether short telomeres may predispose
to radiation sensitivity, we used a modified cell survival
assay that is used in the diagnosis of double-strand break
syndromes such as ataxia-telangiectasia (A-T) (1, 4). We
examined lymphoblastoid cells derived from 7 other telo-
merase and telomere gene mutation carriers (Fig. 1C). Four
of the carriers were asymptomatic, 2 had IPF, and 1 had
bone marrow failure. Cells from these subjects showed
significantly compromised survival compared to controls
and were similarly sensitive to A-T on average (Fig. 1D and
E). In 3 of 7 cases (43%), the surviving fraction at 1 Gy fell
at or below 21%, a threshold considered to be diagnostic ofConflict of interest: none.
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Fig. 1. Clinical features and cell survival of cells with short telomeres after irradiation. (A) Nonhealing open, left anterior
chest wall wound (arrow) after open biopsy and failed grafts. (B) Basilar honeycombing typical of idiopathic pulmonary
fibrosis (arrows). (C) Telogram shows telomere length of mutation carriers relative to that of age-matched controls (nZ192).
Telomeres were measured in peripheral blood lymphocytes by flow cytometry and fluorescence in situ hybridization. Labels
indicate the mutant telomere gene in each case. Red circles refer to individuals whose lymphoblastoid cell lines were studied
in vitro (D and E). (D) Dose response curve shows the surviving fraction of cells at each dose of ionizing radiation. Data are
means from each group of controls, short telomeres, and ataxia telengiectasia (A-T) cells. Each cell line was assayed in
quadruplicate, and the experiment was replicated independently. (E) Individual data points for each case at 1 Gy, a threshold
which has been shown to be useful in the diagnosis of DNA double-strand break syndromes (1). Error bars refer to standard
error of the mean. *P<.05, **P<.01, and ***P<.001, two-sided comparison of differences in surviving fractions relative to
those of controls (Student t test; GraphPad Prism software). ns Z nonsignificant P value.
Stanley et al. International Journal of Radiation Oncology  Biology  Physics1116A-T in some settings (1). Neither the age nor the extent of
the telomere defect predicted the 1-Gy surviving fraction.
Radiation sensitivity and radiation necrosis are rare
complications of radiation therapy, but they are well
documented in patients with defective DNA double-
strand break repair such as A-T (5). The data we showhere indicate that patients with short telomere syndromes
are similarly sensitive to radiation. To our knowledge,
this is the first report of radiation necrosis in a telomerase
mutation carrier. Sensitivity to radiation in the setting of
telomere length abnormalities was first documented in
telomerase null mice with short telomeres (6), and our
Volume 93  Number 5  2015 Increased radiation sensitivity in the Short Telomere Syndromes 1117data highlight the relevance of these observations in
clinical settings.
Syndromes marked by short telomeres manifest as IPF,
emphysema, and aplastic anemia (7). Mutations in telomere
and telomerase genes are the most common cause of familial
pulmonary fibrosis cases, accounting for one-third of cases
(7); they also rival alpha-1 antitrypsin deficiency as a risk
factor for emphysema (8). Short telomere syndrome patients
most often present in mid-to-late adulthood and have no
associated dysmorphic features. A cancer diagnosis is esti-
mated to affect up to 10% of severe cases, such as in dys-
keratosis congenita, and predominantly manifests as
myelodysplasia-acute myeloid leukemia and, more rarely,
squamous cell head and neck carcinomas (9). There are
sparse data regarding cancer treatment outcomes in this
population. After bone marrow transplantation, pulmonary
fibrosis is a nearly uniform complication, and lung shielding
has evolved as a standard to minimize this risk (10).
Awareness of this genetic diagnosis is important in clinical
settings, where ionizing radiation is used such as in assessing
the risk of X rayebased imaging as a screening tool in pul-
monary fibrosis, as well as in a preference for radiation-
sparing regimens in hematopoietic stem cell transplantation.
Patients suspected of having telomere syndromes and who
have a personal or family history of IPF-emphysema, espe-
cially, or myelodysplastic syndrome, should be identifiable by
telomere length measurement combined with genetic testing.References
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